An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
- PMID: 3000618
- DOI: 10.1016/0092-8674(85)90256-9
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
Abstract
Epstein-Barr virus expresses a cytoplasmic and plasma membrane protein (LMP) in latently infected growth transformed lymphocytes. The gene specifying LMP has now been expressed in NIH3T3 and Rat-1 cells. Expression of the gene in these cells resulted in altered cell morphology and some resistance to the growth inhibiting effect of medium containing low serum. In Rat-1 cells, LMP expression often led to loss of contact inhibition and anchorage-independent growth in soft agar. Rat-1 cells expressing LMP were uniformly tumorigenic in nude mice. Thus, LMP is a transforming gene which is likely to account for many aspects of EBV induced cell transformations. This is the first demonstration of a transforming gene in Epstein-Barr virus, a ubiquitous human pathogen associated with neoplasia.
Similar articles
-
The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts.J Virol. 1988 Jul;62(7):2337-46. doi: 10.1128/JVI.62.7.2337-2346.1988. J Virol. 1988. PMID: 2836616 Free PMC article.
-
[Studies on transforming functions of Epstein-Barr virus-specific proteins].Hokkaido Igaku Zasshi. 1990 Jul;65(4):362-75. Hokkaido Igaku Zasshi. 1990. PMID: 2172130 Japanese.
-
Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity.J Virol. 1988 Nov;62(11):4173-84. doi: 10.1128/JVI.62.11.4173-4184.1988. J Virol. 1988. PMID: 2845129 Free PMC article.
-
Human monocytic cell lines transformed in vitro by Epstein-Barr virus display a type II latency and LMP-1-dependent proliferation.J Virol. 2002 Jul;76(13):6460-72. doi: 10.1128/jvi.76.13.6460-6472.2002. J Virol. 2002. PMID: 12050358 Free PMC article.
-
Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.Immunol Lett. 2006 Apr 15;104(1-2):83-8. doi: 10.1016/j.imlet.2005.11.003. Epub 2005 Dec 1. Immunol Lett. 2006. PMID: 16386314 Review.
Cited by
-
Epstein-Barr Virus Oncoprotein LMP1 Mediates Epigenetic Changes in Host Gene Expression through PARP1.J Virol. 2016 Sep 12;90(19):8520-30. doi: 10.1128/JVI.01180-16. Print 2016 Oct 1. J Virol. 2016. PMID: 27440880 Free PMC article.
-
Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.J Virol. 1989 Apr;63(4):1531-9. doi: 10.1128/JVI.63.4.1531-1539.1989. J Virol. 1989. PMID: 2538644 Free PMC article.
-
Embelin prevents LMP1-induced TRAIL resistance via inhibition of XIAP in nasopharyngeal carcinoma cells.Oncol Lett. 2016 Jun;11(6):4167-4176. doi: 10.3892/ol.2016.4522. Epub 2016 May 5. Oncol Lett. 2016. PMID: 27313761 Free PMC article.
-
Levels of Epstein-Barr virus DNA in lymphoblastoid cell lines are correlated with frequencies of spontaneous lytic growth but not with levels of expression of EBNA-1, EBNA-2, or latent membrane protein.J Virol. 1990 Jan;64(1):437-44. doi: 10.1128/JVI.64.1.437-444.1990. J Virol. 1990. PMID: 2152830 Free PMC article.
-
Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization, and cytoskeletal association.J Virol. 1991 Jun;65(6):3246-58. doi: 10.1128/JVI.65.6.3246-3258.1991. J Virol. 1991. PMID: 1827846 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources